companydata.dkJEMO-PHARM A/S: Financial statements 2017
CVR: 10216109
JEMO-PHARM A/S (CVR 10216109) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 9,047,000 and a net result of DKK 522,000 compared with DKK 549,000 the year before. That is an increase of 4.2% compared with the year before. Equity amounted to DKK 2,540,000. The solvency ratio was 8.9%. The company had 17 employees in the financial year.
- Gross Profit
- 9,047,000 kr.
- Profit/Loss
- 522,000 kr.
- Equity
- 2,540,000 kr.
- Total Assets
- 28,407,000 kr.
- Employees
- 17
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 9 mio. | 522 t. | 2.5 mio. | 17 |
| 2016 | - | 8.7 mio. | 549 t. | 2 mio. | 20000 |
| 2015 | - | - | -2.9 mio. | 1.5 mio. | - |
| 2014 | - | 3.5 mio. | -5.4 mio. | 4.4 mio. | - |
| 2013 | - | 11.8 mio. | 1.5 mio. | 9.8 mio. | - |
Find more companies like JEMO-PHARM A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
As of October 4, 2017, Kenneth Bo Codam has left the board of directors of JEMO-PHARM A/S.
As of May 31, 2017, Mark Ole Juel Hemmingsen has joined the board of directors of JEMO-PHARM A/S.
As of May 31, 2017, Bjarne Gribsgaard Olsen has left the board of directors of JEMO-PHARM A/S.
As of May 31, 2017, Kaj Winther-Olsen has left the board of directors of JEMO-PHARM A/S.
JEMO-PHARM A/S has published its annual report for 2016. Gross profit came to DKK 8,683,000, and the net result was DKK 549,000.
About JEMO-PHARM A/S
JEMO-PHARM A/S is a Danish company of the type Aktieselskab based in Stege, founded in 1986. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Mikael Andreas Mohr. The company is owned by THE WHOLE COMPANY A/S and MAM Invest ApS. The company has 27 employees. In 2025, the company reported a gross profit of DKK 11,929,000 and a net result of DKK 30,000 compared with DKK -8,629,000 the year before. Equity amounted to DKK 10,041,000.